David Meek

David Meek possesses extensive experience in the pharmaceutical and biopharmaceutical industries, currently serving as a Member of the Board of Directors for Cullinan Therapeutics and uniQure, and as a member of the Board of Councilors for the USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences. Previous roles include Chief Executive Officer for Mirati Therapeutics and FerGene, as well as Chief Executive Officer at Ipsen. David held significant positions such as Executive Vice President & President of Oncology at Baxalta and Chief Commercial Officer at Endocyte. David's educational background includes a Bachelor of Arts in Business Administration and Management from the University of Cincinnati.